Evidências de medidas de normalidade para a espessura do músculo masseter avaliadas com ultrassonografia: estudo de revisão

Ultrasonographic characteristics of myogenous temporomandibular disorders: A scoping review

OBJECTIVE

To identify the available evidence on the ultrasonographic characteristics of masticatory muscles in subjects with myogenous TMD, as well as the potential use of ultrasonography as a diagnostic and treatment assessment outcomes tool.

METHOD

An electronic search of the PubMed, Web of Science and Scopus databases was performed using the following terms: 'ultrasonography', 'ultrasound', 'masseter', 'temporal', 'masticatory muscles', 'temporomandibular disorders', 'temporomandibular joint disorders'. Full-text articles were obtained from the records after applying the inclusion/exclusion criteria.

RESULTS

Thirteen articles were included for analysis: one comparative cross-sectional study, five case-control studies, six clinical trials and one randomised clinical trial. Main ultrasonographic characteristic assessed were local cross-sectional dimension and intramuscular ultrasonographic appearance. Retrieved studies reported the use ultrasonography for diagnosis or treatment assessment purposes showing heterogeneous results. For diagnosis purposes, the results of local cross-sectional dimension are not consistent; therefore, its diagnostic value for myogenous TMD diagnosis is weak. However, more homogeneous results were observed for intramuscular ultrasonographic appearance showing a higher prevalence of type-II pattern in myogenous TMD subjects than non-TMD subjects. On the other hand, for treatment assessment purposes, muscles were observed thinner after treatment compared to pre-treatment. Also, results of intramuscular ultrasonographic appearance show disappearance or reduction of anechoic areas, higher prevalence of type-II pattern and significant distinction of echogenic bands were observed after treating TMD subjects.

CONCLUSION

Ultrasonography cannot be considered as a diagnostic instrument, but maybe as a complementary tool for treatment assessment of myogenous TMD subjects, even though future research is required to confirm its utility.

A Multicenter Phase II Study Evaluating the Safety and Efficacy of Botulax in Asian Patients with Benign Masseteric Hypertrophy

BACKGROUND

Benign masseteric hypertrophy (BMH) is a condition in which the thickness of the masseter muscle is increased, resulting in jawline prominence with an undesirable cosmetic appearance. Botulinum toxin type A (BTA) injection is a promising treatment option, but its effective dose remains debated.

METHODS

Adults older than 19 diagnosed with BMH through visual examination and palpation related to a masseter muscle prominence were selected, and 80 patients were randomly assigned into five groups (placebo group and four groups with different doses of BTA: 24 U, 48 U, 72 U, or 96 U, on both sides of the jaw) and treated with placebo or BTA once at their baseline visit. During each follow-up, the treatment efficacy was evaluated with ultrasound examination of the masseter muscle, three-dimensional facial contour analysis, visual evaluation by the investigator, and patient satisfaction evaluation.

RESULTS

The mean age of the 80 patients was 42.7 ± 9.98 years; 68.75% were women. The mean change in masseter muscle thickness during the maximum clenching state after 12 weeks of drug administration compared with baseline in the 24-U, 48-U, 72-U, and 96-U groups were -2.33 ± 0.41 mm, -3.35 ± 0.42 mm, -2.86 ± 0.42 mm, and -3.79 ± 0.42 mm, respectively. All treatment groups showed a statistically significant decrease compared with placebo. Regarding subjective satisfaction, all treatment groups, except the 24-U group at 4 weeks, showed higher satisfaction than the placebo group during all visits. No significant adverse events were noted.

CONCLUSION

BTA administration of at least 48 U for BMH is more cost-effective than high-dose units and has a low risk of side effects.

CLINICAL QUESTION/LEVEL OF EVIDENCE

Therapeutic, II.

Relação da espessura e da atividade elétrica do músculo masseter com a força de mordida: um estudo morfológico e eletrofisiológico

RESUMO: Objetivo: estudar a relação da espessura e da atividade elétrica do músculo masseter com a força de mordida. Métodos: participaram do estudo 17 adultos jovens (21,3 ( 1,4 anos), sendo 7 do gênero feminino e 10 do gênero masculino, saudáveis e clinicamente assintomáticos, quanto a disfunções temporomandibulares. Foi efetuada a medida da espessura do músculo masseter unilateralmente, durante o repouso e contração voluntária máxima. Também foi quantificada a força de mordida para cada lado com um transdutor de força posicionado na região do primeiro molar e simultaneamente avaliou-se atividade elétrica do masseter durante a mordida unilateral. A análise foi baseada na comparação das amostras, sendo utilizados o test t, Wilcoxon, Mann-Whitney e regressão linear multivariada. Resultado: a espessura do músculo masseter foi maior nos homens, tanto no repouso quanto em contração. Observou-se uma simetria entre os lados com os músculos em repouso e em contração. A frequência mediana do sinal eletromiográfico, para o músculo masseter em contração voluntária máxima, não apresentou diferença estatisticamente significante intra-indivíduos e na comparação entre os gêneros. Foi encontrada maior força de mordida nos indivíduos do gênero masculino. Não foi encontrado um modelo de regressão linear multivariada entre as variáveis estudadas. Conclusão: neste estudo, não foi possível encontrar um modelo linear com as variáveis estudadas.